Irbm Science Park S.P.A.
Records under this name other than patents Irbm Science Park S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Irbm Science Park S.P.A.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,413,593 | Co-Agonists of the Glucagon and GLP-1 Receptors Formerly held In force · High confidence | In force | High confidence | |
| US 11,773,150 | Antibody Peptide Conjugates That Have Agonist Activity at Both the Glucagon and Glucagon-Like Peptide 1 Receptors Formerly held In force · High confidence | In force | High confidence | |
| US 11,492,385 | Long-Acting Co-Agonists of the Glucagon and GLP-1 Receptors Formerly held In force · High confidence | In force | High confidence | |
| US 10,800,826 | Antibody Peptide Conjugates That Have Agonist Activity at Both the Glucagon and Glucagon-Like Peptide 1 Receptors Formerly held In force · High confidence | In force | High confidence | |
| US 10,493,125 | Co-Agonists of the Glucagon and GLP-1 Receptors Formerly held In force · High confidence | In force | High confidence | |
| US 10,793,615 | Long-Acting Co-Agonists of the Glucagon and GLP-1 Receptors Formerly held In force · High confidence | In force | High confidence | |
| US 10,829,558 | Small Antibody-Like Polypeptides That Bind to EPHA2 Receptor Formerly held In force · High confidence | In force | High confidence | |
| US 11,566,057 | Long-Acting Co-Agonists of the Glucagon and GLP-1 Receptors Formerly held In force · High confidence | In force | High confidence | |
| US 10,364,263 | Cyclic phosphates and cyclic phosphoramidates for the treatment of neurologic disorders Formerly held Lapsed on the fee record Ended Jul 30, 2023 · USPTO record | Lapsed on the fee record | Ended Jul 30, 2023 | USPTO record |
| US 9,782,397 | Treatment of corneal neovascularization Lapsed on the fee record Ended Oct 10, 2021 · USPTO record | Lapsed on the fee record | Ended Oct 10, 2021 | USPTO record |